Comparison of Oral Tolerance to ApoB and HSP60 Peptides in Preventing Atherosclerosis Lesion Formation in Apob48−Ldlr− Mice

Abstract EN

Antigen-specific immune modulation is emerging as an attractive therapeutic option to prevent atherosclerosis.

We compared the efficacy of oral administration of peptides derived from apolipoprotein B (ApoB; 661–680) and heat shock protein 60 (HSP60; 153–163), in the prevention of atherosclerotic lesion formation hyperlipidemic low density lipoprotein receptordeficient (LDLr−/−), apolipoprotein B-100 only (apoB100/100) mice model.

Oral administration of peptides induced tolerance as seen by an increase in regulatory T cells in the peripheral immune system.

Tolerance to ApoB peptide reduced plaque development by 28.7% (P<0.001) while HSP60 was effective in reducing lesion development by 26.8% in ApoB48/LDLr−/− mice.

While tolerance to HSP60 resulted in increase in anti-inflammatory cytokines (IL10 and TGF-β), ApoB tolerance was effective in reducing the lipid deposition in the lesion.

Our results suggest that the two peptides have distinct mechanisms of controlling the development of atherosclerosis in mice.